UB Paderborn / Katalog / Suche / in CDI

1 – 23 von 23

Sortiert nach

Irinotecan Combined With Bolus Fluorouracil, Continuous Infusion Fluorouracil, and High-Dose Leucovorin Every Two Weeks (LV5FU2 Regimen): A Clinical Dose-Finding and Pharmacokinetic Study in Patients With Pretreated Metastatic Colorectal Cancer

Journal of clinical oncology, 1999-09, Vol.17 (9), p.2901-2908

1999

Volltextzugriff (PDF)

Phase I, Dose-Finding, and Pharmacokinetic Study of Raltitrexed Combined With Oxaliplatin in Patients With Advanced Cancer

Journal of clinical oncology, 2000-06, Vol.18 (11), p.2293-2300

2000

Volltextzugriff (PDF)

Mitotane Has an Estrogenic Effect on Sex Hormone-Binding Globulin and Corticosteroid-Binding Globulin in Humans

The journal of clinical endocrinology and metabolism, 2006-06, Vol.91 (6), p.2165-2170

2006

Volltextzugriff (PDF)

Pharmacokinetic profile of cetuximab (Erbitux™) alone and in combination with irinotecan in patients with advanced EGFR-positive adenocarcinoma

European journal of cancer (1990), 2005-08, Vol.41 (12), p.1739-1745

2005

Volltextzugriff (PDF)

Pharmacokinetic advantage of intra-arterial hepatic oxaliplatin administration: comparative results with cisplatin using a rabbit VX2 tumor model

Anti-cancer drugs, 2004-07, Vol.15 (6), p.647-650

2004

Volltextzugriff (PDF)

Pathophysiology and therapy of irinotecan-induced delayed-onset diarrhea in patients with advanced colorectal cancer: a prospective assessment

Journal of clinical oncology, 1998-08, Vol.16 (8), p.2745-2751

1998

Volltextzugriff (PDF)

Post-irradiation hyperamylasemia as a biological dosimeter

Radiotherapy and oncology, 1992-05, Vol.24 (1), p.21-26

1992

Volltextzugriff (PDF)

Portable Blood Gas and Electrolyte Analyzer Evaluated in a Multiinstitutional Study

Clinical chemistry (Baltimore, Md.), 1999-01, Vol.45 (1), p.111-117

1999

Volltextzugriff (PDF)

Successful Rescue in a Patient with High Dose Methotrexate-Induced Nephrotoxicity and Acute Renal Failure

Leukemia & lymphoma, 1998, Vol.29 (1-2), p.205-209

1998

Volltextzugriff (PDF)

High‐dose continuous‐infusion fosfestrol in hormone‐resistant prostate cancer

Cancer, 1993-02, Vol.71 (S3), p.1123-1130

1993

Volltextzugriff (PDF)

Stimulation of tumor growth in vitro and in vivo by suramin on the VX2 model

Investigational new drugs, 1995, Vol.13 (1), p.51-53

1995

Volltextzugriff (PDF)

Stimulation of tumor growthin vitro andin vivo by suramin on the VX2 model

Investigational new drugs, 1995-03, Vol.13 (1), p.51-53

1995

Volltextzugriff (PDF)

Thymidylate synthase activity, folates, and glutathione system in head and neck carcinoma and adjacent tissues

Head & neck, 1994-03, Vol.16 (2), p.158-164

1994

Volltextzugriff (PDF)

Phase II trial of LY 186641 in advanced renal cancer

Investigational new drugs, 1993-12, Vol.11 (4), p.323-328

1993

Volltextzugriff (PDF)

Etude de certains inhibiteurs de la dopamine-beta-hydroxylase (EC-1-14-2-1) leur action sur le metabolisme de la serotonine

Bonnay, Marc

1974

Volltextzugriff (PDF)

A new anticancer agent (LY186641) interferes with creatinine assay

Cancer chemotherapy and pharmacology, 1989-01, Vol.23 (2), p.119-120

1989

Volltextzugriff (PDF)

Evidence for a peripheral effect of fusaric acid, a dopamine β-hydroxylase inhibitor, on serotonin metabolism

Biochemical pharmacology, 1974-10, Vol.23 (19), p.2770-2773

1974

Volltextzugriff (PDF)

Hyd ubiquitinates the NF-κB co-factor Akirin to operate an effective immune response in Drosophila

PLoS pathogens, 2020-04, Vol.16 (4), p.e1008458-e1008458

2020

Volltextzugriff (PDF)

Akirin specifies NF-κB selectivity of Drosophila innate immune response via chromatin remodeling

The EMBO journal, 2014-10, Vol.33 (20), p.2349-2362

2014

Volltextzugriff (PDF)

big bang gene modulates gut immune tolerance in Drosophila

Proceedings of the National Academy of Sciences - PNAS, 2013-02, Vol.110 (8), p.2957-2962

2013

Volltextzugriff (PDF)

The SUMO-targeted ubiquitin ligase, Dgrn, is essential for Drosophila innate immunity

The International journal of developmental biology, 2017-01, Vol.61 (3-4-5), p.319

2017

Volltextzugriff (PDF)

Hyd ubiquitinates the NF-[kappa]B co-factor Akirin to operate an effective immune response in Drosophila

PLoS pathogens, 2020-04, Vol.16 (4)

2020

Volltextzugriff (PDF)

Akirin specifies NF-[kappa]B selectivity of Drosophila innate immune response via chromatin remodeling

The EMBO journal, 2014-10, Vol.33 (20), p.2349

2014

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(22)
Dissertationen
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(18)
Life Sciences & Biomedicine
(17)
Humans
(13)
Male
(11)
Oncology
(11)
Biological And Medical Sciences
(9)
Female
(8)
Medical Sciences
(8)
Adult
(7)
Aged
(7)
Middle Aged
(7)
Pharmacology. Drug Treatments
(7)
Animals
(6)
Antineoplastic Agents
(5)
Drosophila
(5)
Pharmacology & Pharmacy
(5)
Chemotherapy
(4)
Antineoplastic Combined Chemotherapy Protocols - Pharmacokinetics
(3)
Area Under Curve
(3)
Bacteria
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Irinotecan Combined With Bolus Fluorouracil, Continuous Infusion Fluorouracil, and High-Dose Leucovorin Every Two Weeks (LV5FU2 Regimen): A Clinical Dose-Finding and Pharmacokinetic Study in Patients With Pretreated Metastatic Colorectal Cancer

Phase I, Dose-Finding, and Pharmacokinetic Study of Raltitrexed Combined With Oxaliplatin in Patients With Advanced Cancer

Mitotane Has an Estrogenic Effect on Sex Hormone-Binding Globulin and Corticosteroid-Binding Globulin in Humans

Pharmacokinetic profile of cetuximab (Erbitux™) alone and in combination with irinotecan in patients with advanced EGFR-positive adenocarcinoma

Pharmacokinetic advantage of intra-arterial hepatic oxaliplatin administration: comparative results with cisplatin using a rabbit VX2 tumor model

Pathophysiology and therapy of irinotecan-induced delayed-onset diarrhea in patients with advanced colorectal cancer: a prospective assessment

Post-irradiation hyperamylasemia as a biological dosimeter

Portable Blood Gas and Electrolyte Analyzer Evaluated in a Multiinstitutional Study

Successful Rescue in a Patient with High Dose Methotrexate-Induced Nephrotoxicity and Acute Renal Failure

High‐dose continuous‐infusion fosfestrol in hormone‐resistant prostate cancer

Stimulation of tumor growth in vitro and in vivo by suramin on the VX2 model

Stimulation of tumor growthin vitro andin vivo by suramin on the VX2 model

Thymidylate synthase activity, folates, and glutathione system in head and neck carcinoma and adjacent tissues

Phase II trial of LY 186641 in advanced renal cancer

Etude de certains inhibiteurs de la dopamine-beta-hydroxylase (EC-1-14-2-1) leur action sur le metabolisme de la serotonine

A new anticancer agent (LY186641) interferes with creatinine assay

Evidence for a peripheral effect of fusaric acid, a dopamine β-hydroxylase inhibitor, on serotonin metabolism

Hyd ubiquitinates the NF-κB co-factor Akirin to operate an effective immune response in Drosophila

Akirin specifies NF-κB selectivity of Drosophila innate immune response via chromatin remodeling

big bang gene modulates gut immune tolerance in Drosophila

The SUMO-targeted ubiquitin ligase, Dgrn, is essential for Drosophila innate immunity

Hyd ubiquitinates the NF-[kappa]B co-factor Akirin to operate an effective immune response in Drosophila

Akirin specifies NF-[kappa]B selectivity of Drosophila innate immune response via chromatin remodeling

Suchergebnisse filtern